Saroja Pharma Industries India Past Earnings Performance
Past criteria checks 2/6
Saroja Pharma Industries India has been growing earnings at an average annual rate of 20.2%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 1.2% per year. Saroja Pharma Industries India's return on equity is 6%, and it has net margins of 2.2%.
Key information
20.2%
Earnings growth rate
-37.6%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | 1.2% |
| Return on equity | 6.0% |
| Net Margin | 2.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Saroja Pharma Industries India makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 407 | 9 | 15 | 0 |
| 30 Sep 23 | 448 | 10 | 16 | 0 |
| 30 Jun 23 | 475 | 10 | 16 | 0 |
| 31 Mar 23 | 502 | 11 | 16 | 0 |
| 31 Mar 22 | 556 | 11 | 13 | 0 |
| 31 Mar 21 | 367 | 7 | 10 | 0 |
| 31 Mar 20 | 171 | 2 | 8 | 0 |
Quality Earnings: SAROJA has a high level of non-cash earnings.
Growing Profit Margin: SAROJA's current net profit margins (2.2%) are higher than last year (2.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SAROJA's earnings have grown significantly by 20.2% per year over the past 5 years.
Accelerating Growth: SAROJA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SAROJA had negative earnings growth (-17.2%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).
Return on Equity
High ROE: SAROJA's Return on Equity (6%) is considered low.